Association between C/EBPß downstream proteins and arteriosclerosis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054493

Enrollment

Unknown

Registered

2021-12-18

Start date

2021-12-15

Completion date

Unknown

Last updated

2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adults aged over 18 years.

Exclusion criteria

Exclusion criteria: 1. Clear vascular inflammatory disease, autoimmune disease; 2. A clear diagnosis of malignant tumor; 3. Use of antihypertensive drugs or vascular protective drugs; 4. History of diabetes.

Design outcomes

Primary

Measure	Time frame
Pulse wave velocity;Platelet-derived growth factor CC;Nuclear factor kappa B receptor activator ligand;	—

Countries

China

Contacts

Public ContactChen Xiaoping

West China Hospital of Sichuan University

xiaopingchen23@163.com+86 18980601226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026